Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

Pages

5:50am

Fri January 17, 2014
Shots - Health News

Surgeon General Adds New Risks To Long List Of Smoking's Harms

Originally published on Fri January 17, 2014 11:39 am

John Hartigan, proprietor of Vapeology LA, a store selling electronic cigarettes and related items, takes a puff from an electronic cigarette in Los Angeles.
Reed Saxon AP

Acting Surgeon General Boris Lushniak is the latest in a long line of surgeons general who have tried to pound the final nails into the coffin of America's smoking habit.

Read more

1:32pm

Fri January 10, 2014
Shots - Health News

Half Of A Drug's Power Comes From Thinking It Will Work

Originally published on Fri January 10, 2014 1:37 pm

iStockphoto

When you take a pill, you and your doctor hope it will work — and that helps it work.

That's not a new idea. But now researchers say they know just how much of a drug's effect comes from the patient's expectation: at least half.

When patients in the midst of a migraine attack took a dummy pill they thought was a widely used migraine drug, it reduced their pain roughly as much as when they took the real drug thinking it was a placebo.

Read more

3:39pm

Tue January 7, 2014
Shots - Health News

50 Years After Landmark Warning, 8 Million Fewer Smoking Deaths

Originally published on Wed January 8, 2014 1:22 pm

Tobacco companies incorporated doctors in their ads, such as this 1930 Lucky Strike campaign, to convince the public that smoking wasn't harmful.
Stanford University

Saturday marks an important milestone in public health – the 50th anniversary of the first Surgeon General's Report on Smoking and Health.

Few if any documents have had the impact of this one — both on the amount of disease and death prevented, and on the very scope of public health.

Read more

1:22am

Mon December 30, 2013
Shots - Health News

$1,000 Pill For Hepatitis C Spurs Debate Over Drug Prices

Originally published on Thu February 6, 2014 1:43 pm

Federal regulators this month opened a new era in the treatment of a deadly liver virus that infects three to five times more people than HIV. Now the question is: Who will get access to the new drug for hepatitis C, and when?

The drug Sovaldi will cost $1,000 per pill. A typical course of treatment will last 12 weeks and run $84,000, plus the cost of necessary companion drugs. Some patients may need treatment for twice as long.

Read more

8:15am

Thu December 12, 2013
Shots - Health News

Tagging Along On A Wisconsin Man's Odyssey To Buy Insurance

Originally published on Thu December 12, 2013 12:47 pm

Doug Normington is 58, self-employed, and has diabetes.
Courtesy of Doug Normington

Enrollment is picking up in new health insurance marketplaces. But the 365,000 who've signed up as of November 30 is a fraction of just one high-visibility group – those whose previous insurance has been cancelled because it didn't meet Affordable Care Act standards.

They're people like Doug Normington, a 58-year-old self-employed videographer in Madison, Wis., who has struggled to buy new insurance since late October.

Read more

Pages